CDK4 and acute myeloid leukemia: CDK4/6: These mediators stimulate G1 progression and bind/sequester CDK inhibitors (CKI), e.g., p14, p16, p27 [98]. p14 and p27 can show increased expression in AML, p16 may show low expression [106].